These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 26659802

  • 1. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
    Yu L.
    Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
    [Abstract] [Full Text] [Related]

  • 2. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
    Yu L, Dong F, Miao D, Fouts AR, Wenzlau JM, Steck AK.
    Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
    [Abstract] [Full Text] [Related]

  • 3. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
    Miao D, Steck AK, Zhang L, Guyer KM, Jiang L, Armstrong T, Muller SM, Krischer J, Rewers M, Yu L, Type 1 Diabetes TrialNet Study Group.
    Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
    [Abstract] [Full Text] [Related]

  • 4. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, Huang G, Zhou Z, Liu Y.
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [Abstract] [Full Text] [Related]

  • 5. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ, Winkler C, Chmiel R, Matzke C, Scholz M, Beyerlein A, Achenbach P, Bonifacio E, Ziegler AG.
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [Abstract] [Full Text] [Related]

  • 6. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
    Miao D, Guyer KM, Dong F, Jiang L, Steck AK, Rewers M, Eisenbarth GS, Yu L.
    Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
    Steck AK, Fouts A, Miao D, Zhao Z, Dong F, Sosenko J, Gottlieb P, Rewers MJ, Yu L, TrialNet Study Group.
    Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
    [Abstract] [Full Text] [Related]

  • 11. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J, Lempainen J, Hammais A, Laine AP, Härkönen T, Toppari J, Veijola R, Knip M, Finnish Pediatric Diabetes Register.
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [Abstract] [Full Text] [Related]

  • 12. Type 1 diabetes islet autoantibody markers.
    Winter WE, Harris N, Schatz D.
    Diabetes Technol Ther; 2002 Mar; 4(6):817-39. PubMed ID: 12614488
    [Abstract] [Full Text] [Related]

  • 13. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH, Tappaz M, Durand A, Petersen J, Stefanutti A, Chatelain P, Vialettes B, Scherbaum W, Orgiazzi J.
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [Abstract] [Full Text] [Related]

  • 14. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
    Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E, Achenbach P.
    Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
    [Abstract] [Full Text] [Related]

  • 15. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C, Kolmodin M, Ivarsson SA, Carlsson A, Forsander G, Lindblad B, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Ortqvist E, Lernmark A, Elding Larsson H, Törn C, Better Diabetes Diagnosis Study Group.
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [Abstract] [Full Text] [Related]

  • 16. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
    Sosenko JM, Yu L, Skyler JS, Krischer JP, Gottlieb PA, Boulware D, Miao D, Palmer JP, Steck AK.
    Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.